Literature DB >> 19139600

Flow-mediated vasodilation as a diagnostic modality for vascular failure.

Teruo Inoue1, Hidehiro Matsuoka, Yukihito Higashi, Shin-Ichiro Ueda, Masataka Sata, Ken-Ei Shimada, Yutaka Ishibashi, Koichi Node.   

Abstract

Vascular endothelial dysfunction represents an initial step of "vascular failure," which we have recently proposed as a comprehensive syndrome of failed vascular functions that extends from risk factors to established atherosclerotic disease. The early detection of vascular failure is essential in order to appropriately intervene and prevent its progression. Many efforts have been made to assess vascular endothelial function, and one of the most promising methods is the measurement of endothelium-dependent flow-mediated vasodilation (FMD) using high-frequency ultrasonographic imaging and transient occlusion of the brachial artery. The reactive hyperemia caused by the transient brachial arterial occlusion induces the release of local nitric oxide, resulting in vasodilation that can be quantified as an index of vasomotor function. The noninvasive nature of this technique allows repeated measurements over time to study the effectiveness of various interventions that may affect vascular health. Although there are technical and interpretive limitations of this technique, FMD-guided therapeutic approaches for vascular failure should contribute to the improvement of cardiovascular mortality and morbidity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19139600     DOI: 10.1291/hypres.31.2105

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  28 in total

1.  The comparison of endothelial function between conduit artery and microvasculature in patients with coronary artery disease.

Authors:  Emi Tajima; Masashi Sakuma; Seiko Tokoi; Hisae Matsumoto; Fumiya Saito; Ryo Watanabe; Shigeru Toyoda; Shichiro Abe; Teruo Inoue
Journal:  Cardiol J       Date:  2018-08-29       Impact factor: 2.737

2.  Short-term physical inactivity impairs vascular function.

Authors:  Emily V Nosova; Priscilla Yen; Karen C Chong; Hugh F Alley; Eveline O Stock; Alex Quinn; Jason Hellmann; Michael S Conte; Christopher D Owens; Matthew Spite; S Marlene Grenon
Journal:  J Surg Res       Date:  2014-02-12       Impact factor: 2.192

3.  The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocol.

Authors:  Masashi Sakuma; Shigeru Toyoda; Takuo Arikawa; Yota Koyabu; Toru Kato; Taichi Adachi; Hideaki Suwa; Jun-Ichi Narita; Koetsu Anraku; Kimihiko Ishimura; Fumitake Yamauchi; Yasunori Sato; Teruo Inoue
Journal:  Clin Exp Nephrol       Date:  2018-06-18       Impact factor: 2.801

4.  Sildenafil increases uterine blood flow in nonpregnant nulliparous women.

Authors:  Sarah A Hale; Cresta W Jones; George Osol; Adrienne Schonberg; Gary J Badger; Ira M Bernstein
Journal:  Reprod Sci       Date:  2010-04       Impact factor: 3.060

5.  Modeling vascular inflammation and atherogenicity after inhalation of ambient levels of ozone: exploratory lessons from transcriptomics.

Authors:  Andrea Tham; Dominic Lullo; Sarah Dalton; Siyang Zeng; Ian van Koeverden; Mehrdad Arjomandi
Journal:  Inhal Toxicol       Date:  2017-04-16       Impact factor: 2.724

6.  Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study.

Authors:  Toru Kato; Teruo Inoue; Koichi Node
Journal:  Cardiovasc Diabetol       Date:  2010-03-24       Impact factor: 9.951

Review 7.  The Relationship between Vascular Function and the Autonomic Nervous System.

Authors:  Eisuke Amiya; Masafumi Watanabe; Issei Komuro
Journal:  Ann Vasc Dis       Date:  2014-05-16

8.  Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI).

Authors:  Peter A McCullough; Josee Bouchard; Sushrut S Waikar; Edward D Siew; Zoltan H Endre; Stuart L Goldstein; Jay L Koyner; Etienne Macedo; Kent Doi; Salvatore Di Somma; Andrew Lewington; Ravi Thadhani; Raj Chakravarthi; Can Ice; Mark D Okusa; Jacques Duranteau; Peter Doran; Li Yang; Bertrand L Jaber; Shane Meehan; John A Kellum; Michael Haase; Patrick T Murray; Dinna Cruz; Alan Maisel; Sean M Bagshaw; Lakhmir S Chawla; Ravindra L Mehta; Andrew D Shaw; Claudio Ronco
Journal:  Contrib Nephrol       Date:  2013-05-13       Impact factor: 1.580

9.  Reduction in blood pressure improves impaired nitroglycerine-induced vasodilation in patients with essential hypertension.

Authors:  Tatsuya Maruhashi; Ayumu Nakashima; Shinji Kishimoto; Akimichi Iwamoto; Masato Kajikawa; Nozomu Oda; Yasuki Kihara; Yoshiki Aibara; Kensuke Noma; Yukihito Higashi
Journal:  Hypertens Res       Date:  2015-09-03       Impact factor: 3.872

10.  Masked hypertension defined by home blood pressure monitoring is associated with impaired flow-mediated vasodilatation in patients with cardiovascular risk factors.

Authors:  Tomoyuki Kabutoya; Satoshi Hoshide; Yukiyo Ogata; Kazuo Eguchi; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-06-25       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.